Treatment of Oligometastatic EGFR-Mutant Lung Cancer

(MedPage Today) -- EGFR tyrosine kinase inhibitors (TKIs) are effective treatments for EGFR-mutant non-small cell lung cancer (NSCLC). However, even after undergoing systemic therapy, patients may have oligometastatic disease.
"A lot of patients...